First Time Loading...
T

Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 5 870 ILS 0.95% Market Closed
Updated: May 10, 2024
Section:
 

Wall Street
Price Targets

TEVA Price Targets Summary
Teva Pharmaceutical Industries Ltd

There are no price targets for TEVA.
TEVA Lowest Forecast
Wall Street Target
Not Available
TEVA Average Forecast
Wall Street Target
Not Available
TEVA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Teva Pharmaceutical Industries Ltd Competitors:
Price Targets
W
016580
Whanin Pharm Co Ltd
49% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
47% Upside
H
300199
Hybio Pharmaceutical Co Ltd
19% Upside
BAI
BenevolentAI SA
362% Upside
W
016580
Whanin Pharm Co Ltd
49% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
47% Upside
H
300199
Hybio Pharmaceutical Co Ltd
19% Upside
BAI
BenevolentAI SA
362% Upside
FULC
Fulcrum Therapeutics Inc
80% Upside
H
000908
Hunan Jingfeng Pharmaceutical Co Ltd
686% Upside
E
EAH
ECO Animal Health Group PLC
79% Upside
OCUL
Ocular Therapeutix Inc
171% Upside

Revenue
Forecast

Revenue Estimate
Teva Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's revenue is -3%. The projected CAGR for the next 3 years is 2%.

-3%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Teva Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -4%. The projected CAGR for the next 3 years is 9%.

-4%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Teva Pharmaceutical Industries Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
TEVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
TEVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TEVA stock valuation using valuation multiples.
Wall Street Estimates
TEVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TEVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TEVA's stock price target?
Not Available

TEVA doesn't have any price targets made by Wall Street professionals.

What is Teva Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's revenue is -3%. The projected CAGR for the next 3 years is 2%.

What is Teva Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -4%. The projected CAGR for the next 3 years is 9%.

ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.